Companies in #Antiviral Antibodies

RQ Bio is a UK-based biotechnology company developing a portfolio of virus-targeting monoclonal antibodies. The company emerged from research at the Rosalind Franklin Institute and raised a $115M Series A in 2026 to advance its preclinical pipeline of broadly neutralizing antibodies against viral pathogens.